Avgemsi Injection, Solution
Product Images NDC 83831-124

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Avgemsi (NDC 83831-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure01)

This text contains information about a treatment regimen involving Gemcitabine and Carboplatin for the progression-free survival of patients, which is expressed in months. The specific duration or results of the treatment are not available in the extracted text.*

FDA Label Image

Figure 2 (Figure02)

FDA Label Image

Figure 3 (Figure03)

FDA Label Image

Figure 4 (Figure04)

The text appears to be a table showing the percentage of survival rates for different time periods after treatment with Gemcitabine. The table displays fractions surviving at various time points.*

FDA Label Image

Image Description (Image0005)

FDA Label Image

Image Description (Image004)

FDA Label Image

Image Description (Image006)

Not available.*

FDA Label Image

Image Description (Image01)

FDA Label Image

Image Description (Image02)

FDA Label Image

Image Description (Image03)

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.